5//SEC Filing
Anthera Pharmaceuticals Inc 5
Accession 0001214659-17-000747
CIK 0001316175operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:34 PM ET
Size
4.9 KB
Accession
0001214659-17-000747
Insider Transaction Report
Form 5
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
- Award
Common Stock
2017-01-11$0.55/sh+7,190$3,955→ 7,190 total
Footnotes (1)
- [F1]Represents 7,190 shares acquired under the Issuer's 2010 Employee Stock Purchase Plan for the offering period ended December 31, 2016.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 5
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 6:34 PM ET
- Size
- 4.9 KB